Source: ERJ Open Res, 2 (4) 00027-2016; 10.1183/23120541.00027-2016
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
John-Paul Westwood, Alexander J. Mackay, Gavin Donaldson, Samuel J. Machin, Jadwiga A. Wedzicha, Marie Scully. The role of complement activation in COPD exacerbation recovery. ERJ Open Res, 2 (4) 00027-2016; 10.1183/23120541.00027-2016

Member's Comments

No comment yet.

Related content which might interest you: The role of infections as a trigger of COPD exacerbations and decline of lung function Source: Annual Congress 2011 - Epidemiology of COPD exacerbations Year: 2011 Does inflammation decrease after recovery from severe exacerbation of COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 53s Year: 2005 The inflammasome pathway in stable COPD and acute exacerbations Source: ERJ Open Res 2016: 00002-2016 Year: 2016 The role of viruses in COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 577s Year: 2006 Influence of infection and α1-proteinase inhibitor on inflammatory response in COPD exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 417s Year: 2003 COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Characterisation of a model that mimics aspects of the hyper-inflammatory response observed during an acute exacerbation of COPD. Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 PP301 – The role of the systemic inflammation in bronchiectasis exacerbation frequency Source: ERS Lung Science Conference 2021 Year: 2021 The role of neutrophils in severe asthma Source: Annual Congress 2012 - Are neutrophils a suitable target in severe asthma? Year: 2012 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Role of activated complement in COPD exacerbation recovery Source: International Congress 2014 – Comorbidities Year: 2014 Extracellular nucleotides contribute to the pathogenesis of viral-induced exacerbations in COPD via P2X4/P2X7-receptor activation Source: International Congress 2019 – Mechanisms underlying respiratory infection Year: 2019 The effectiveness of early pulmonary rehabilitation in acute exacerbation of COPD in the terms of functional and systemic markers. Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 The role of bacteria in COPD exacerbations Source: International Congress 2014 – PG04 Update on COPD exacerbations Year: 2014 Association of systemic inflammation with clinical recovery in patients with acute exacerbation of COPD Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury Source: ERS Lung Science Conference 2017 Year: 2017 Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Activation of the inflammasome pathway during exacerbations of COPD Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Upregulated expression of interleukin-33 and alternative activation of macrophages in a model of an acute exacerbation of asthma Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011 The role of viruses as trigger factors for asthma exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 639s Year: 2004